Eslicarbazepine Acetate Monotherapy Long Term Study

Clinical trial NCT00910247 · COMPLETED

Trial details

NCT number

NCT00910247

Sponsor

Sumitomo Pharma America, Inc.

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2009-08-01

Primary completion

2017-04-15

Enrollment

274

View on ClinicalTrials.gov